Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private
BSE857.0042.5 (+5.22 %)
PREV CLOSE () 814.50
OPEN PRICE () 820.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 107066
TODAY'S LOW / HIGH ()811.05 866.70
52 WK LOW / HIGH ()260 835.15
NSE855.8040.85 (+5.01 %)
PREV CLOSE() 814.95
OPEN PRICE () 819.00
BID PRICE (QTY) 855.80 (759)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3006284
TODAY'S LOW / HIGH() 811.25 866.65
52 WK LOW / HIGH ()259.5 834.1
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1987

Management Info :

Omprakash Inani - Chairman Vishnukant Bhutada - Managing Director

Registered Office :

Address : Shilpa House,#12-6-214/ A1,Hyderabad Road,
Raichur,
Karnataka-584135

Phone : 08532-238704

Website : www.vbshilpa.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
03Aug Shilpa Medicare informs about appointm
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
29Jul Shilpa Medicare informs about board me
Shilpa Medicare has informed that the Meeting of the Board of Directors..
30Jun Shilpa Medicare informs about disclo
Pursuant to Regulation 30 read with other applicable provisions of the S..
24Jun Shilpa Medicare’s arm commissions Anti
Shilpa Medicare’s material subsidiary -- Shilpa Biologicals has commissi..
24Jun Shilpa Medicare informs about press r
Shilpa Medicare has informed that it enclosed a press release on announc..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit649.21329.7
Gross Profit 510.6 1481.3
Operating Profit 655.71938.6
Net Sales 1890.45970.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26450.00 (0.78%)
M.Cap ( in Cr)
56140.66
Kwality Pharma (BSE)
 3450.00 (2.77%)
M.Cap ( in Cr)
3604.54
Bharat Parenterals (BSE)
 1469.95 (6.29%)
M.Cap ( in Cr)
1013.08
Glenmark Pharma. (BSE)
 2386.60 (3.50%)
M.Cap ( in Cr)
67355.74
Orchid Pharma (BSE)
 1038.20 (4.09%)
M.Cap ( in Cr)
6219.38
Shareholding Pattern
NON-INSTITUTION 40.43%
PROMOTERS 40.13%
MUTUAL FUNDS/UTI 4.21%
FI/BANKS/INSURANCE 2.31%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77369.11-171.72 (-0.22%)
NIFTY24219.05-32.95 (-0.14%)
Dow Jones 53277.01517.80 (0.98%)
Nasdaq 26180.46113.29 (0.43%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI